Sign in
4

Changes in Ownership

Evofem Biosciences, Inc. Filed Acc 0001618835-18-000109

Chief Commercial Officer bought 279 shares at $3.55 ($990)

From the SEC's structured data for this filing

Trades in this filing

Barrans Russell · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-11-21 Purchase : show line 1 in the form +279 $3.55 $990 12,820 I
Open-market purchases · 279 sh · avg $3.55 · $990
Loading xslF345X03/wf-form4_154326280693538.xml…